AVRA Company Updates
On February 14, 2017, AVRA filed a Registration on Form S-1 with the U.S. Securities and Exchange Commission covering the resale of certain of our outstanding shares of common stock with a view to becoming a fully reporting public company.
On July 31, 2017 the S1 was deemed effective by the SEC.
On January 31, 2019 AVRA Medical Robotics’ CEO Mr. Barry Cohen released letter to update Shareholders
ORLANDO, FL – May 8, 2019 – AVRA Medical Robotics, Inc. (the “Company”) (OTCQB:AVMR), an emerging company that is creating the next generation of autonomous surgical robotics through the use of technologies such as artificial intelligence, machine learning and proprietary medical software architecture, announced today that it has retained The Horizon Phoenix Group and its principal Mr. Timothy K. Duggins as a regulatory consultant. The company entered into a four-year contract to conduct regulatory work on behalf of AVRA..
For more Information regarding investor relations please call us at (1) 407 956 2250 – Extension 9 or email us via the contact form.